Pay in 4 interest-free payments of $5.84 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
Interaction Neuronal cells, myoblast, T cells, B cells, NK cells Ligand/Receptor IGF-I receptor, Insulin receptor isoform A, and IGF-II receptor (M-6-P-R) Bioactivity Human LR3 IGF-1 induces the proliferation of MCF-7 human epithelial cells
Other Savings Options If your Aetna plan does not cover Mounjaro or Zepbound, you can save on your out-of-pocket costs by: Signing up for a free BuzzRx prescription discount card
Retatrutide is a novel triagonist peptide that simultaneously targets three critical metabolic receptors: Glucagon-like peptide-1 (GLP-1) Glucose-dependent insulinotropic polypeptide (GIP) Glucagon Originally developed for clinical research into obesity and metabolic disorders, retatrutide is designed to support extensive scientific exploration of: Weight reduction Improved glucose management Enhanced metabolic function What Key Benefits Does Retatrutide Offer
Wegovy is FDA-approved for long-term weight management in adults who are fat or overweight and who suffer from at least one weight-related illness, such as type 2 diabetes, high blood pressure, or high cholesterol
McCall McPhereson: I love it
US$ 25.70
US$ 27.45
US$ 29.28
US$ 29.15
US$ 28.15
US$ 23.91
